Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$806M |
| 2 |
AbbVie
ABBV
|
+$481M |
| 3 |
T-Mobile US
TMUS
|
+$464M |
| 4 |
Kroger
KR
|
+$430M |
| 5 |
Baidu
BIDU
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.35B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
S
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$488M |
| 5 |
Humana
HUM
|
+$450M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.45% |
| 2 | Technology | 16.09% |
| 3 | Consumer Staples | 10.57% |
| 4 | Consumer Discretionary | 9.95% |
| 5 | Communication Services | 9.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Church & Dwight Co
CHD
$24.4B
| $133M | 0.12% |
1,726,352
-509,948
| -23% | -$37.1M |
|
177
Hormel Foods
HRL
$13.4B
| $133M | 0.11% |
2,755,613
+1,623,154
| +143% | +$77.6M |
|
178
Ubiquiti
UI
$34.7B
| $132M | 0.11% |
757,382
+16,200
| +2% | +$2.72M |
|
|
SNP
179
DELISTED
CHINA PETROLEUM & CHEMICAL CORPORATION ADS (REP 100 ORDINARY H SHARES)
SNP
| $131M | 0.11% |
3,130,604
+332,900
| +12% | +$15.7M |
|
|
SWCH
180
DELISTED
Switch, Inc. Class A Common Stock
SWCH
| $130M | 0.11% |
7,291,063
-156,002
| -2% | -$2.73M |
|
181
Usana Health Sciences
USNA
$254M
| $130M | 0.11% |
1,768,666
+186,966
| +12% | +$14.7M |
|
182
Check Point Software Technologies
CHKP
$13.2B
| $129M | 0.11% |
1,202,509
+770,501
| +178% | +$81.6M |
|
183
Tenaris
TS
$27B
| $129M | 0.11% |
9,975,848
+1,217,400
| +14% | +$16.1M |
|
184
Crocs
CROX
$6.31B
| $128M | 0.11% |
3,475,311
-1,334,800
| -28% | -$35.3M |
|
185
ZTO Express
ZTO
$17.6B
| $128M | 0.11% |
3,474,400
+1,920,700
| +124% | +$61.2M |
|
186
Lumentum
LITE
$63.8B
| $128M | 0.11% |
1,566,242
-650,900
| -29% | -$49.6M |
|
187
Medifast
MED
$130M
| $127M | 0.11% |
915,910
+22,000
| +2% | +$2.02M |
|
188
Wells Fargo
WFC
$264B
| $126M | 0.11% |
4,916,926
+1,833,315
| +59% | +$50.2M |
|
189
Sturm, Ruger & Co
RGR
$598M
| $126M | 0.11% |
1,653,276
+221,500
| +15% | +$13.5M |
|
190
W.W. Grainger
GWW
$61.3B
| $125M | 0.11% |
398,900
+75,300
| +23% | +$21.8M |
|
191
Dr. Reddy's Laboratories
RDY
$10.4B
| $125M | 0.11% |
11,759,690
+1,784,450
| +18% | +$18.2M |
|
192
Alamos Gold
AGI
$14B
| $124M | 0.11% |
13,231,956
+30,485
| +0.2% | +$234K |
|
193
Ambev
ABEV
$43.8B
| $123M | 0.11% |
46,525,386
-1,432,490
| -3% | -$3.38M |
|
194
Enbridge
ENB
$113B
| $123M | 0.11% |
4,031,781
-1,221,900
| -23% | -$37.5M |
|
|
CEO
195
DELISTED
CNOOC Limited
CEO
| $123M | 0.11% |
1,086,474
+53,000
| +5% | +$5.98M |
|
196
Dolby
DLB
$5.75B
| $122M | 0.11% |
1,848,357
-176,400
| -9% | -$10.6M |
|
|
VMW
197
DELISTED
VMware, Inc
VMW
| $122M | 0.11% |
785,767
+14,627
| +2% | +$2.01M |
|
|
CZZ
198
DELISTED
Cosan Limited
CZZ
| $122M | 0.11% |
8,074,794
-903,648
| -10% | -$11.8M |
|
199
AXIS Capital
AXS
$7.35B
| $121M | 0.1% |
2,980,213
+287,984
| +11% | +$11.1M |
|
200
AngloGold Ashanti
AU
$49.3B
| $120M | 0.1% |
4,081,635
+578,950
| +17% | +$14.3M |
|
Similar funds
Jim Simons's Q2 2020 Portfolio in Review
As of Q2 2020, Jim Simons held 3,987 positions worth $116B, up 13% from $103B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Jim Simons withdrew a net $8.24B in Q2 2020, closing 596 positions and reducing 1,366 holdings. Its most notable exit was Allergan plc, an estimated $1.26B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 25% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Jim Simons opened a new position in Uber worth $187M.
- Jim Simons's largest Q2 2020 buy was Uber: 6,030,316 shares worth $187M.
- Jim Simons added most to Zoom in Q2 2020, an estimated $806M increase.
- Jim Simons's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.35B.
- Jim Simons fully exited Allergan plc in Q2 2020, selling an estimated $1.26B.
- Jim Simons's ten largest holdings make up 14% of its $116B portfolio in Q2 2020.
- Jim Simons opened 584 new positions and closed 596 in Q2 2020.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $116B.
Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.